Skip to search formSkip to main contentSkip to account menu

OSI-7836

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Purpose: To determine the maximum tolerated dose (MTD), recommended phase II dose (RP2D), safety, tolerability, toxicity profile… 
2006
2006
Purpose: To investigate the safety, tolerability, and pharmacokinetic profile of the novel nucleoside analogue OSI-7836 in… 
2006
2006
4′-Thio-β-d-arabinofuranosylcytosine (OSI-7836) is a nucleoside analogue with structural similarity to gemcitabine and cytarabine… 
2006
2006
Purpose:To investigate the safety, tolerability, and pharmacokinetic profile of the novel nucleoside analogue OSI-7836 in… 
2004
2004
OSI-7836 (4′-thio-β-d-arabinofuranosylcytosine) is a novel nucleoside analog in phase I clinical development for the treatment of… 
2004
2004
Proc Amer Assoc Cancer Res, Volume 45, 2004 2973 OSI-7836, a nucleoside analog in development for the treatment of solid…